Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.fermentabiotech.com | |
Market Cap | 499.00 Cr. | |
Enterprise Value(EV) | 698.79 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -3.64 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 121.80 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 1.39 | Calculated using Price: 168.75 |
Dividend Yield | 0.74 | Period Ending 2022-03 |
No. of Shares Subscribed | 2.94 Cr. | 29,430,987 Shares |
FaceValue | 5 | |
Company Profile | ||
Currently, DIL is engaged in the business of research support services through its subsidiary Research Support International Ltd. (RSIL), manufacture and marketing of enzymes and chemicals through its subsidiary Fermenta Biotech Ltd. (FBL), entertainment through its subsidiary White Stripes Entertainment Ltd. (WSEL) and manufacture and marketing of levitation technology and wheel chairs through its Joint Venture company, being set up in the Czech Republic. |
1 Day |
|
-4.04% |
1 Week |
|
-4.61% |
1 Month |
|
-4.50% |
3 Month |
|
-13.73% |
6 Month |
|
-12.81% |
1 Year |
|
-40.57% |
2 Year |
|
-42.12% |
5 Year |
|
-23.23% |
10 Year |
|
+261.58% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 8.47 | 0.72 | 2.08 | -6.00 | 40.79 | 64.77 | 21.92 | 13.05 | 4.27 | |
Return on Capital Employed (%) | 10.54 | 3.68 | 6.18 | 1.96 | 33.86 | 40.16 | 12.98 | 12.62 | 7.50 | |
Return on Assets (%) | 4.55 | 0.37 | 0.99 | -2.76 | 15.85 | 25.73 | 10.75 | 6.56 | 2.04 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 133 | 132 | 130 | 144 | 124 | 251 | 309 | 361 | 372 | 358 | |
Non Curr. Liab. | 33 | 14 | 24 | 48 | 146 | 125 | 72 | 131 | 154 | 112 | |
Curr. Liab. | 71 | 94 | 108 | 86 | 104 | 156 | 195 | 230 | 228 | 203 | |
Minority Int. | 22 | 22 | 26 | 28 | 11 | 0 | 0 | 0 | -1 | -1 | |
Equity & Liab. | 259 | 262 | 288 | 307 | 385 | 532 | 576 | 722 | 753 | 671 | |
Non Curr. Assets | 145 | 171 | 195 | 203 | 202 | 226 | 292 | 391 | 419 | 367 | |
Curr. Assets | 114 | 91 | 93 | 104 | 182 | 296 | 284 | 330 | 335 | 304 | |
Misc. Exp. not W/O | 10 | ||||||||||
Total Assets | 259 | 262 | 288 | 307 | 385 | 532 | 576 | 722 | 753 | 671 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 139 | 142 | 155 | 164 | 303 | 405 | 293 | 377 | 399 | 379 | |
Other Income | 3 | 0 | 1 | 3 | 11 | 27 | 14 | 8 | 8 | 11 | |
Total Income | 142 | 142 | 156 | 167 | 314 | 431 | 307 | 386 | 407 | 390 | |
Total Expenditure | -113 | -126 | -135 | -152 | -212 | -269 | -229 | -295 | -336 | -351 | |
PBIDT | 30 | 16 | 21 | 15 | 102 | 162 | 79 | 91 | 70 | 39 | |
Interest | -5 | -5 | -6 | -10 | -14 | -21 | -20 | -19 | -18 | -18 | |
Depreciation | -10 | -9 | -8 | -10 | -12 | -12 | -15 | -20 | -26 | -29 | |
Taxation | -3 | -2 | -4 | -3 | -21 | -11 | 16 | -9 | -12 | -4 | |
Exceptional Items | |||||||||||
PAT | 11 | 1 | 3 | -8 | 55 | 118 | 60 | 43 | 15 | -12 | |
Minority Interest | -2 | 0 | -3 | -3 | -13 | 0 | 0 | 3 | 0 | 1 | |
Share Associate | -1 | 0 | -1 | 0 | -8 | 0 | |||||
Other Related Items | |||||||||||
Consolidated Net Profit | 8 | 0 | -1 | -11 | 34 | 117 | 60 | 46 | 15 | -11 | |
Adjusted EPS | 3 | 0 | 0 | -4 | 12 | 43 | 21 | 16 | 5 | -4 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 23 | 14 | 15 | 4 | 2 | 59 | 90 | 34 | 63 | 43 | |
Cash Fr. Inv. | -20 | -25 | -18 | -13 | 7 | -101 | -97 | -44 | -42 | -26 | |
Cash Fr. Finan. | -8 | 13 | 1 | 10 | -12 | 89 | 12 | -47 | -1 | -22 | |
Net Change | -4 | 2 | -2 | 1 | -4 | 47 | 6 | -57 | 20 | -4 | |
Cash & Cash Eqvt | 4 | 6 | 3 | 5 | -15 | 32 | 38 | -18 | 2 | -2 |
Thu, 26 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we inform you that the Company has received information from the shareholder about loss of share certificates on January 25 2023 |
Wed, 18 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we inform you that the Company has received an intimation from its Registrar and Transfer Agent - Link Intime India Private Limited on January 17 2023 regarding issue of duplicate share certificate to the shareholder. |
Tue, 17 Jan 2023
Execution Of Sale Deed Further to our earlier intimation dated June 9 2022 in relation to the members approval obtained to sell lease or otherwise dispose of the portion of Companys assets being premises located in Thane One Building DIL Complex Ghodbunder Road Majiwade Thane (West) 400 610 we wish to inform you that the Company has executed and registered a sale deed on January 17 2023 to sell premises situated at the 7th floor in Thane One Building DIL Complex Ghodbunder Road Majiwade Thane (West) 400 610 on the terms and conditions mentioned in the sale deed and as approved by the Board of Directors of the Company.The information regarding the aforesaid sale of premises is provided in Annex-A herewith.This intimation is given under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for your records. |
Fri, 27 Jan 2023 |
|
|
|
|
|